Protara Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-08-16: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Series A Convertible Preferred Stock which is convertible into Common Stock, $.001 par value.; Date of first sale 2017-08-02; Total offering amount $22,000,000.
- 2014-02-19: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; Date of first sale 2013-09-04; Total offering amount $4,338,660.
- 2011-08-11: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2011-08-02; Total offering amount $15,183,371.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2017-08-16 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired; Series A Convertible Preferred Stock which is convertible into Common Stock, $.001 par value. | 2017-08-02 | $22,000,000 | $22,000,000 | $0 | 11 |
|---|
| 2014-02-19 | Rule 506(b) | Equity; Debt; OptionToAcquire | 2013-09-04 | $4,338,660 | $4,338,660 | $0 | 17 |
|---|
| 2011-08-11 | Rule 506 | Equity; OptionToAcquire | 2011-08-02 | $15,183,371 | $15,183,371 | $0 | 19 |
|---|